---
reference_id: "PMID:35595414"
title: Conventional Therapies for Crohn's Disease.
authors:
- Rolak S
- Kane SV
journal: Gastroenterol Clin North Am
year: '2022'
doi: 10.1016/j.gtc.2021.12.004
content_type: abstract_only
---

# Conventional Therapies for Crohn's Disease.
**Authors:** Rolak S, Kane SV
**Journal:** Gastroenterol Clin North Am (2022)
**DOI:** [10.1016/j.gtc.2021.12.004](https://doi.org/10.1016/j.gtc.2021.12.004)

## Content

1. Gastroenterol Clin North Am. 2022 Jun;51(2):271-282. doi: 
10.1016/j.gtc.2021.12.004. Epub 2022 Apr 22.

Conventional Therapies for Crohn's Disease.

Rolak S(1), Kane SV(2).

Author information:
(1)Department of Internal Medicine, Mayo Clinic College of Medicine and Science, 
200 First Street, Southwest, Rochester, MN 55905, USA. Electronic address: 
Rolak.stacey@mayo.edu.
(2)Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, 200 First 
Street, Southwest, Rochester, MN 55905, USA.

Crohn's disease is a chronic and progressive immune-mediated disease with 
increasing incidence worldwide. There are no curative therapies. The primary 
agents used in the treatment of Crohn's disease are aminosalicylates, 
corticosteroids, immunomodulators, and biologics. Each agent has different roles 
in the induction and maintenance of remission of disease. The biologics 
available include anti-TNF agents, anti-integrins, and anti-interleukins. The 
choice of initial biologic therapy should be determined through shared 
decision-making between the patient and provider.

Copyright Â© 2022 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.gtc.2021.12.004
PMID: 35595414 [Indexed for MEDLINE]